tradingkey.logo
搜索

Cassava Sciences Ord Shs

FLNA
添加自选
0.425USD
-0.023-5.13%
收盘 11-13 16:00(美东)
20.53M总市值
亏损市盈率 TTM

关于 Cassava Sciences Ord Shs 公司

Cassava Sciences, Inc. is a clinical-stage biopharmaceutical company focused on developing novel, investigational treatments for central nervous system disorders, including Alzheimer’s disease and tuberous sclerosis complex (TSC)-related seizures. The Company's science is based on stabilizing, but not removing, a critical protein in the brain for patients with disorders such as Alzheimer’s disease or TSC. It has two biopharmaceutical assets under development: Simufilam and SavaDx. Simufilam, its lead therapeutic product candidate, is an oral treatment for Alzheimer’s disease and TSC-related epilepsy. Simufilam targets an altered form of a protein called filamin A (FLNA) in the brain of patients with disorders such as Alzheimer’s disease or TSC. SavaDx, its lead investigational diagnostic product candidate, early-stage program focused on detecting the presence of Alzheimer’s disease from a small sample of blood.

Cassava Sciences Ord Shs 简介

公司代码- -
公司名称- -
上市日期- -
CEO- -
员工数量- -
证券类型- -
年结日- -
公司地址- -
城市- -
上市交易所- -
国家- -
邮编- -
电话- -
网址- -
公司代码- -
上市日期- -
CEO- -

Cassava Sciences Ord Shs公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Richard J. (Rick) Barry
Mr. Richard J. (Rick) Barry
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
938.06K
+49.94%
Mr. Richard J. (Rick) Barry
Mr. Richard J. (Rick) Barry
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
938.06K
+49.94%
Mr. Richard J. (Rick) Barry
Mr. Richard J. (Rick) Barry
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
938.06K
+49.94%
Mr. Eric J. Schoen
Mr. Eric J. Schoen
Chief Financial Officer
Chief Financial Officer
11.50K
--
Mr. Eric J. Schoen
Mr. Eric J. Schoen
Chief Financial Officer
Chief Financial Officer
11.50K
--
Mr. Eric J. Schoen
Mr. Eric J. Schoen
Chief Financial Officer
Chief Financial Officer
11.50K
--
Dr. Robert Z. Gussin, Ph.D.
Dr. Robert Z. Gussin, Ph.D.
Independent Director
Independent Director
10.62K
--
Mr. Michael J. O'Donnell, Esq.
Mr. Michael J. O'Donnell, Esq.
Independent Director
Independent Director
6.87K
--
Dr. Patrick J. Scannon, M.D., Ph.D.
Dr. Patrick J. Scannon, M.D., Ph.D.
Independent Director
Independent Director
--
--
Dr. Angelique Bordey, Ph.D.
Dr. Angelique Bordey, Ph.D.
Senior Vice President - Neuroscience
Senior Vice President - Neuroscience
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Richard J. (Rick) Barry
Mr. Richard J. (Rick) Barry
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
938.06K
+49.94%
Mr. Richard J. (Rick) Barry
Mr. Richard J. (Rick) Barry
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
938.06K
+49.94%
Mr. Richard J. (Rick) Barry
Mr. Richard J. (Rick) Barry
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
938.06K
+49.94%
Mr. Eric J. Schoen
Mr. Eric J. Schoen
Chief Financial Officer
Chief Financial Officer
11.50K
--
Mr. Eric J. Schoen
Mr. Eric J. Schoen
Chief Financial Officer
Chief Financial Officer
11.50K
--
Mr. Eric J. Schoen
Mr. Eric J. Schoen
Chief Financial Officer
Chief Financial Officer
11.50K
--

常见问题

Cassava Sciences Ord Shs的前五大股东是谁?

Cassava Sciences Ord Shs 的前五大股东如下:Mr. Richard J. (Rick) Barry
tradingkey.logo
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有